Pharsight

REVANCE THERAPEUTICALS INC patents facing oppositions

Top patents of REVANCE THERAPEUTICALS INC facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3368071B1 26 Jan, 2022 Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect Oct, 2036 1
EP2661276B1 02 Aug, 2017 Topical composition comprising botulinum toxin and a dye Dec, 2031 1